Recently, a study discovered more information about metastasis as it relates to colon cancer. Metastasis is when part of a cancer cell breaks off and spreads to other parts of the body. The majority of all cancer deaths arise from metastasis, 90 percent to be exact. Around 25 percent of colon cancer patients discover that cancer cells have made their way to the liver and lungs. Scientists have been conducting studies that have helped them understand more about metastasis. These studies will help them figure out ways to prevent this process from occurring so frequently.
TOPK and PRPK are new and anti-metastatic important therapy techniques. TOPK is expressed strongly in human metastatic colorectal cancer tissue. TOPK actually promotes metastasis of colorectal cancer by modulating PRPK, which is a novel prognostic maker for survival of patients with colon cancer.
Dr. Tatyana Zykova has been involved with a lot of the studies. She says, “We are excited about these data that provide a better understanding of both prevention of metastasis and prognosis of colon cancer treatment.”
She is really confident that these studies can make an huge impact in the way colon cancer is being treated. The scientists and researchers will continue to expand on their findings and hope it will eventually lead to prevention or the treatment of colon cancer.